205 related articles for article (PubMed ID: 36319643)
1. FOXQ1 recruits the MLL complex to activate transcription of EMT and promote breast cancer metastasis.
Mitchell AV; Wu L; James Block C; Zhang M; Hackett J; Craig DB; Chen W; Zhao Y; Zhang B; Dang Y; Zhang X; Zhang S; Wang C; Gibson H; Pile LA; Kidder B; Matherly L; Yang Z; Dou Y; Wu G
Nat Commun; 2022 Nov; 13(1):6548. PubMed ID: 36319643
[TBL] [Abstract][Full Text] [Related]
2. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis.
Zhang H; Meng F; Liu G; Zhang B; Zhu J; Wu F; Ethier SP; Miller F; Wu G
Cancer Res; 2011 Feb; 71(4):1292-301. PubMed ID: 21285253
[TBL] [Abstract][Full Text] [Related]
3. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression.
Xia L; Huang W; Tian D; Zhang L; Qi X; Chen Z; Shang X; Nie Y; Wu K
Hepatology; 2014 Mar; 59(3):958-73. PubMed ID: 24005989
[TBL] [Abstract][Full Text] [Related]
4. Forkhead factor FOXQ1 promotes TGF-β1 expression and induces epithelial-mesenchymal transition.
Fan DM; Feng XS; Qi PW; Chen YW
Mol Cell Biochem; 2014 Dec; 397(1-2):179-86. PubMed ID: 25287361
[TBL] [Abstract][Full Text] [Related]
5. FOXQ1 promotes gastric cancer metastasis through upregulation of Snail.
Zhang J; Liu Y; Zhang J; Cui X; Li G; Wang J; Ren H; Zhang Y
Oncol Rep; 2016 Jun; 35(6):3607-13. PubMed ID: 27109028
[TBL] [Abstract][Full Text] [Related]
6. Suppression of forkhead box Q1 by microRNA-506 represses the proliferation and epithelial-mesenchymal transition of cervical cancer cells.
Zhang M; Xu Q; Yan S; Li Z; Yan W; Jia X
Oncol Rep; 2016 May; 35(5):3106-14. PubMed ID: 26935526
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal transrepression between FOXF2 and FOXQ1 controls basal-like breast cancer aggressiveness.
Kang LJ; Yu ZH; Cai J; He R; Lu JT; Hou C; Wang QS; Li XQ; Zhang R; Feng YM
FASEB J; 2019 May; 33(5):6564-6573. PubMed ID: 30807702
[TBL] [Abstract][Full Text] [Related]
8. Nuclear isoform of RAPH1 interacts with FOXQ1 to promote aggressiveness and radioresistance in breast cancer.
Liu Q; Cao Y; Wei X; Dong H; Cui M; Guan S; Liu B; Wang X; Xing P
Cell Death Dis; 2023 Dec; 14(12):803. PubMed ID: 38062011
[TBL] [Abstract][Full Text] [Related]
9. Short hairpin RNA targeting FOXQ1 inhibits invasion and metastasis via the reversal of epithelial-mesenchymal transition in bladder cancer.
Zhu Z; Zhu Z; Pang Z; Xing Y; Wan F; Lan D; Wang H
Int J Oncol; 2013 Apr; 42(4):1271-8. PubMed ID: 23403865
[TBL] [Abstract][Full Text] [Related]
10. FOXQ1 regulates epithelial-mesenchymal transition in human cancers.
Qiao Y; Jiang X; Lee ST; Karuturi RK; Hooi SC; Yu Q
Cancer Res; 2011 Apr; 71(8):3076-86. PubMed ID: 21346143
[TBL] [Abstract][Full Text] [Related]
11. The oncogenic transcription factor FOXQ1 is a differential regulator of Wnt target genes.
Pizzolato G; Moparthi L; Söderholm S; Cantù C; Koch S
J Cell Sci; 2022 Oct; 135(19):. PubMed ID: 36124643
[TBL] [Abstract][Full Text] [Related]
12. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
[No Abstract] [Full Text] [Related]
13. PDGFRα and β play critical roles in mediating Foxq1-driven breast cancer stemness and chemoresistance.
Meng F; Speyer CL; Zhang B; Zhao Y; Chen W; Gorski DH; Miller FR; Wu G
Cancer Res; 2015 Feb; 75(3):584-93. PubMed ID: 25502837
[TBL] [Abstract][Full Text] [Related]
14. FOXQ1 mediates the crosstalk between TGF-β and Wnt signaling pathways in the progression of colorectal cancer.
Peng X; Luo Z; Kang Q; Deng D; Wang Q; Peng H; Wang S; Wei Z
Cancer Biol Ther; 2015; 16(7):1099-109. PubMed ID: 25955104
[TBL] [Abstract][Full Text] [Related]
15. Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells.
Guo J; Yan Y; Yan Y; Guo Q; Zhang M; Zhang J; Goltzman D
Oncol Rep; 2017 Oct; 38(4):2003-2010. PubMed ID: 28791370
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the role of FOXQ1 in colorectal cancer metastasis.
Abba M; Patil N; Rasheed K; Nelson LD; Mudduluru G; Leupold JH; Allgayer H
Mol Cancer Res; 2013 Sep; 11(9):1017-28. PubMed ID: 23723077
[TBL] [Abstract][Full Text] [Related]
17. The tumor suppressor p53 is a negative regulator of the carcinoma-associated transcription factor FOXQ1.
Pizzolato G; Moparthi L; Pagella P; Cantù C; D'Arcy P; Koch S
J Biol Chem; 2024 Apr; 300(4):107126. PubMed ID: 38432629
[TBL] [Abstract][Full Text] [Related]
18. DDR2 coordinates EMT and metabolic reprogramming as a shared effector of FOXQ1 and SNAI1.
Mitchell AV; Wu J; Meng F; Dong L; Block CJ; Song WM; Zhang B; Li J; Wu G
Cancer Res Commun; 2022 Nov; 2(11):1388-1403. PubMed ID: 36713812
[TBL] [Abstract][Full Text] [Related]
19. Involvement of FoxQ1 in NSCLC through regulating EMT and increasing chemosensitivity.
Feng J; Xu L; Ni S; Gu J; Zhu H; Wang H; Zhang S; Zhang W; Huang J
Oncotarget; 2014 Oct; 5(20):9689-702. PubMed ID: 25356753
[TBL] [Abstract][Full Text] [Related]
20. MiR-1271 Inhibits Cell Proliferation, Invasion and EMT in Gastric Cancer by Targeting FOXQ1.
Xiang XJ; Deng J; Liu YW; Wan LY; Feng M; Chen J; Xiong JP
Cell Physiol Biochem; 2015; 36(4):1382-94. PubMed ID: 26159618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]